-
March 10, 2022 Psychedelic Researchers Doubt Microdosing in New York TimesAfter a disappointing microdosing study, Dr. Michiel van Elk says the trend is "just not...
-
March 9, 2022 Oklahoma House Passes Psilocybin Decriminalization BillNow it's up to the state's Senate to consider the bill decriminalizing the possession of...
-
March 8, 2022 The Best Cities for a Psychedelic Trip, Vol. 1These destinations give “a quick weekend trip” a whole new meaning.
-
March 7, 2022 Is Wall Street the Next Stop for Psychedelics? Investing in the Psychedelic Medicine SectorElemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future...
-
March 5, 2022 Is There a Difference Between Tripping on LSD and Psilocybin?A double-blinded, randomized, and placebo-controlled study compares the subjective and autonomic effects of both psychedelics.
-
March 3, 2022 Study Finds Psilocybin Anti-Depression Effects Last at Least One YearA year after a Johns Hopkins psilocybin-assisted therapy study, researchers find the number of people...
-
March 2, 2022 The Biggest Reason People in Oregon Want to Use PsilocybinSpoiler alert: It's not because they're depressed.
-
March 1, 2022 The Road to Psychedelics LegalizationMatthew X. Lowe, Ph.D., the Research Director of Unlimited Sciences, explains why observational research is...
-
February 25, 2022 Psychedelic Business Spotlight – February 25This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon;...
-
February 23, 2022 4 Signs the Psychedelics Movement Is UnstoppableWith no strong resistance manifesting to oppose the psychedelic renaissance, it appears these drugs have...
